Study to Evaluate the Effect of a Probiotic in COVID-19

Bioithas

Status: Completed

Conditions: COVID-19; Coronavirus Infection

Treatments: Dietary Supplement: Probiotic

Study type: Interventional

Funder types: Industry

Identifiers

NCT04390477

COVID.PROB

Details and patient eligibility

About

A prospective case-control pilot study to evaluate the possible effect of a probiotic mixture in the improvement of symptoms, the reduction in the number of days of hospitalization and the increase in the percentage of patients with negative PCR after infection with the coronavirus SARS-CoV-2.

Full description

In this study, the investigators hypothesize a positive effect of probiotic on the gut microbiome that could led to produce a less severe clinical evolution of the disease.

Enrollment: 41 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with a confirmed diagnosis of SARS-Cov.2 infection using the PCR and that require admission to the hospitalization area.

Exclusion criteria

• Inability or refusal to sign informed consent.
• Allergy or intolerance to the intervention product or its components.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

41 participants in 2 patient groups

Probiotic

Experimental group

Description:

1 pill od containing 1x10E9 cfu of the probiotic

Treatment:

Dietary Supplement: Probiotic

Control

No Intervention group

Description:

No treatment